Vega, Anabeth .
HRN: 25-53-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
CEFUROXIME 500MG (TAB)
07/31/2024
08/06/2024
PO
500mg
BID
S/P NSVD WITH RLME
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes